1. Home
  2. MRAM vs ENTA Comparison

MRAM vs ENTA Comparison

Compare MRAM & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$32.29

Market Cap

327.8M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.50

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ENTA
Founded
2008
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
374.6M
IPO Year
2016
2012

Fundamental Metrics

Financial Performance
Metric
MRAM
ENTA
Price
$32.29
$13.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$18.50
$20.40
AVG Volume (30 Days)
5.8M
178.7K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.93
EPS
N/A
N/A
Revenue
$49,417,000.00
$102,814,000.00
Revenue This Year
$10.22
$7.76
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.51
16.48
52 Week Low
$5.49
$5.78
52 Week High
$51.50
$17.15

Technical Indicators

Market Signals
Indicator
MRAM
ENTA
Relative Strength Index (RSI) 59.11 44.79
Support Level $8.48 $13.19
Resistance Level $51.50 $13.76
Average True Range (ATR) 5.91 0.81
MACD -0.59 -0.11
Stochastic Oscillator 41.27 13.87

Price Performance

Historical Comparison
MRAM
ENTA

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: